The U.S. depyrogenated sterile empty vials market size is likely to reach USD 3.5 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.2% during the forecast period. Technological advancements in the pharmaceutical packaging process, growing funding by government organizations, and flourishing biologics market in the U.S. are some of the key trends in escalating market growth. Stringent regulations laid by the government for parenteral are also poised to augment the market.
Rising number of clinical labs in the country is resulting in an increased number of medical and diagnostic tests. This, in turn, is fueling the demand for depyrogenated sterile empty vials. Increasing number of compounding laboratories and research institutes in the U.S. is boosting the demand for these vials in the market. Moreover, continual growth in the pharmaceutical and biotechnology industry is further projected to drive the market.
Increasing number of collaborations in order to achieve innovative packaging technology is also providing an upthrust to the market. Rising incidence of infectious & non-infectious diseases and the growing number of clinical studies are translating into greater demand for these vials. Besides this, the government is backing the promotion of pharmaceutical, medical, and biotechnological researches, which is anticipated to work in favor of the market.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/us-depyrogenated-sterile-empty-vials-market
U.S. Depyrogenated Sterile Empty Vials Market Report Highlights
• More than 20 ml depyrogenated sterile empty vials emerged as the largest segment in terms of revenue in 2017 owing to rising incidence of infectious & non-infectious diseases and increasing investments in the biopharmaceutical sector
• Others, which include pharmaceutical manufacturers and academic & research institutes, formed the most prominent end-use segment in 2017. The growth of the segment can be attributed to the expanding base of medical & biotech research institutes and an upswing in pharmaceutical manufacturing
• Thermo Fisher Scientific, Inc.; Gerresheimer AG; SCHOTT AG; and DWK Life Sciences are the major players operating in the market. This market is considerably fragmented and the market entry barrier is high.
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/us-depyrogenated-sterile-empty-vials-market/request/rs1
U.S. Depyrogenated Sterile Empty Vials Market Segmentation
Grand View Research has segmented the U.S. depyrogenated sterile empty vials market on the basis of product and end-use:
Depyrogenated Sterile Empty Vials Product Outlook (Revenue, USD Million, 2014 – 2025)
• 2 ml
• 5 ml
• 10 ml
• 20 ml
• More than 20 ml
Depyrogenated Sterile Empty Vials End-use Outlook (Revenue, USD Million, 2014 – 2025)
• Clinical Labs
• Compounding Labs
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/5478/ibb
About Grand View Research
Grand View Research is a market research and consulting company based in the State of California with headquarters in San Francisco. The company offers consulting services tailored for business organizations to assist them with understanding and exploring their potential on a large scale. At the same time, Grand View Research caters to the individual research needs to provide a customized research service.
Grand View Research is fully committed to offer the best research services in the Industry. Our dedicated team of experienced analysts offer full capability and potential to precisely understand your research needs.
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
Country: United States